Phraction Management’s iShares US Medical Devices ETF IHI Stock Holding History

Phraction Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$548K	Hold	11,091	–	–	0.09%	51
2026 Q1	$592K	Hold	11,091	–	–	0.12%	50
2025 Q4	$689K	Buy	11,091 +1,075	+11%	+$66.4K	0.18%	50
2025 Q3	$602K	Hold	10,016	–	–	0.17%	52
2025 Q2	$627K	Hold	10,016	–	–	0.2%	55
2025 Q1	$603K	Hold	10,016	–	–	0.2%	47
2024 Q4	$584K	Hold	10,016	–	–	0.2%	49
2024 Q3	$593K	Hold	10,016	–	–	0.21%	44
2024 Q2	$561K	Hold	10,016	–	–	0.21%	43
2024 Q1	$587K	Hold	10,016	–	–	0.23%	44
2023 Q4	$541K	Hold	10,016	–	–	0.22%	40
2023 Q3	$486K	Hold	10,016	–	–	0.23%	40
2023 Q2	$566K	Hold	10,016	–	–	0.28%	36
2023 Q1	$541K	Hold	10,016	–	–	0.31%	35
2022 Q4	$527K	Buy	10,016 +1,350	+16%	+$68.5K	0.35%	34
2022 Q3	$409K	Hold	8,666	–	–	0.31%	40
2022 Q2	$437K	Buy	8,666 +1,750	+25%	+$95.4K	0.29%	49
2022 Q1	$422K	Buy	+6,916	New	+$412K	0.24%	51

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Phraction Management's IHI Position: Q2 2026 in Review

Phraction Management held its iShares US Medical Devices ETF (IHI) position steady in Q2 2026 at 11,091 shares worth $548K. The position accounts for 0.09% of the portfolio, ranked #51.

Phraction Management first reported a position in IHI in Q1 2022 and has held it in 18 quarters since. The position peaked at $689K in Q4 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

Phraction Management held 11,091 shares of iShares US Medical Devices ETF worth $548K as of Q2 2026.
Phraction Management left its iShares US Medical Devices ETF share count unchanged in Q2 2026.
iShares US Medical Devices ETF made up 0.09% of Phraction Management's portfolio in Q2 2026, its #51 holding.
Phraction Management first reported a position in iShares US Medical Devices ETF in Q1 2022 and has held it in 18 quarters since.
Phraction Management's iShares US Medical Devices ETF position peaked at $689K in Q4 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Phraction Management's 13F filing for Q2 2026, filed 20 Jul 2026.